angiotensin IV (Human) [870]
angiotensin IV (Human)
| SMILES | CC[C@H](C)[C@H](NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@@H](N)C(C)C)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1ccccc1)C(=O)O |
| InChIKey | QSBGWDDCOJYQGY-KOQODJNWSA-N |
| Sequence | VYIHPF |
| HELM | PEPTIDE1{V.Y.I.H.P.F}$$$$ |
Chemical Properties
| Hydrogen bond acceptors | 9 |
| Hydrogen bond donors | 8 |
| Rotatable bonds | 19 |
| Log P | 1.187 |
| Molecular weight (Da) | 774.4 |
| Stereochemistry info | partial |
Database connections
| Model (AF2) | AT1 |
Bioactivities
| Receptor | Activity | Source | |||||||
|---|---|---|---|---|---|---|---|---|---|
| Protein | Gene | Species | Family | Class | Type | Min | Avg | Max | Database |
| Receptor | Activity | Source | |||||||
|---|---|---|---|---|---|---|---|---|---|
| Protein | Gene | Species | Family | Class | Type | Min | Avg | Max | Database |
angiotensin IV (Human)
Drug properties
| Molecular type | Peptide |
| Physiological/Surrogate | Endogenous |
| Approved drug | No |
Distribution across phases (no. indications)
Phase I
0
Phase II
0
Phase III
0
Phase IV
0
Database connections
| Model (AF2) | AT1 |